Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer.
Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer.
复制标题
表皮生长因子受体的外显子 4 缺失变体增强了上皮性卵巢癌的侵袭性和顺铂耐药性。
DOI:
10.1093/carcin/bgt216
复制
发表时间:
2013-11
期刊:
影响因子:
4.7
通讯作者:
Hong Sun
中科院分区:
文献类型:
--
作者:
Zonghai Li;Pengfei Zhang;Min Zhou;Hua Jiang;Haiyan Zhang;Bizhi Shi;Xiaorong Pan;Huiping Gao;Hong Sun
Recently, de4 EGFR, a variant of epidermal growth factor receptor (EGFR) with exon 4 deletion, was identified in glioblastoma and ovarian cancer. However, its biological function on ovarian cancer is still not clear. In this study, the expression profile
登录
查看更多内容
影响因子:
120.1
作者:
Daniel Jones
通讯作者:
Daniel Jones
DOI:
10.1891/9780826121646.0002
发表时间:
2018-09
期刊:
Cancer Rehabilitation
影响因子:
--
作者:
K. Miller;R. Siegel;R. Khan;A. Jemal
通讯作者:
K. Miller;R. Siegel;R. Khan;A. Jemal
DOI:
10.3410/f.1016920.201638
发表时间:
2004-01
期刊:
--
影响因子:
--
作者:
K. Green
通讯作者:
K. Green
影响因子:
3.9
作者:
Bansal N;Marchion DC;Bicaku E;Xiong Y;Chen N;Stickles XB;Sawah EA;Wenham RM;Apte SM;Gonzalez-Bosquet J;Judson PL;Hakam A;Lancaster JM
通讯作者:
Lancaster JM
影响因子:
4.8
作者:
Antonyak, MA;Moscatello, DK;Wong, AJ
通讯作者:
Wong, AJ